4.2 Review

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms

Journal

PHARMACOGENOMICS
Volume 9, Issue 5, Pages 625-637

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/14622416.9.5.625

Keywords

CYP1A2; enzyme activity; interindividual variation; pharmacogenetics; phenotyping; polymorphisms

Ask authors/readers for more resources

CYP1A2 is involved in the metabolism of several widely used drugs and endogenous compounds, and in the activation of procarcinogens. Both genetic and environmental factors influence the activity of this enzyme. The current knowledge regarding factors influencing the activity of CYP1A2 is summarized in this review. Substrates, inhibitors and inducers of CYP1A2 activity, as well as phenotyping probes, are discussed. The functional significance and clinical importance of CYP1A2 gene polymorphisms are reviewed and interethnic differences in the distribution of CYP1A2 variant alleles and haplotypes are summarized. Finally, future perspectives for the possible clinical applications of CYP1A2 genotyping are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available